"Regulation of Glia-Driven Neuroimmune Mechanisms of Alzheimer´s Disease"
Professor Andis Klegeris. Faculty of Sciences, University of British Columbia, Okanagan Campus, Canada.
Viernes, 4 de abril, 12 h. Salón de Grados A, Facultad de Medicina.
“Deciphering the Enigmatic Role of γδ T cells in Solid Cancers”
Dr. Kilian Wistuba-Hamprecht
Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, and Department of Dermatology, Venereology and Allergology, University Medical Center, Mannheim, Ruprecht-Karl University of Heidelberg, Germany
Día 21 de marzo. Salon de Actos A, Facultad de Medicina
"Generation of myeloid-derived suppressor cells (MDSC) in cancer and their targeting."
Prof. Viktor Umansky
Viernes, 7 de marzo de 2025
"Beyond the Surface: Targeting Cancer-Enriched Intracellular Proteins to Expand the Immunotherapy Antigen Repertoire"
Dr. Annelisa Cornel. Princess Máxima Center for Pediatric Oncology (The Netherlands)
Friday, 17th January, 2025. 12:00 pm
Salón de Actos de GENyO
Contact:
Karim Benabdellah:
Wharton's jelly differentiation towards hepatocyte-like cells: comparison between totally defined and serum-containing media.
Prof. Giampiero La Rocca
Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo.
"The molecular chaperone TRAP1in cancer progression"
Prof. Andrea Rasola
Dipartimento di Scienze BiomedicheUniversità di Padova, Italia
Ly9 (CD229) a SLAM family immunoreceptor: Bridging Basic Research and Clinical Applications.
Dr. Pablo Engel Rocamora
Sección de Inmunología. Dpto. de Ciencias Biomédicas, Universidad de Barcelona. Federación Europea de Sociedades Inmunológicas (EFIS).
Presentación de nuestro Máster para el curso académico 24-25
Día: 22 de octubre de 2024
Hora: 16 h.
Lugar: Salón de Grados A, Facultad de Medicina, PTS.
Inborn errors of immunity- what we learn from patients.
Dr. Hirotsugu Oda. Principal Investigator - University of Cologne.
Día 10 de mayo de 2024
“Desarrollo de probióticos para enfermedades inflamatorias: el ejemplo de Limosilactobacillus fermentum”
Dr. Julio Gálvez Peralta
Departamento de Farmacología y Centro de Investigación Biomédica (CIBM), Universidad de Granada
Día 26 de abril, 2024
